OSU starts anti-cancer vax trial; Gates compares Microsoft to vax philanthropy;

Vaccine Research

Australia's Hunter Immunology has started recruitment for a 340-patient, 23-site trial for its oral COPD vaccine, HI 164OV. Hunter release

Researchers at the Ohio State University Comprehensive Cancer Center have started a Phase I trial investigating the safety of an anticancer vaccine. The vax targets two regions of human epidermal growth factor receptor 2 (HER-2) and HER-1, which are prevalent in various types of cancer. OSU release

Vaccine Market

While in India promoting tuberculosis vaccine research, Bill Gates likened his philanthropic efforts to building up Microsoft. "In my work at Microsoft, my job was hiring talented engineers to solve tough problems that look unsolvable and backing their work for five or 10 years and understanding what works and what doesn't work," he said. "At the foundation, it is similar... Running the foundation is a lot like running a software innovation company." Article

An outbreak of pertussis at La Cañada High School in California has led school administrators to push for student vaccinations. News

Cooper Animal Health's new bovine respiratory disease vaccine is now on the market. It is the only vaccine that targets both the bacterial and viral culprits for the disease--the leading killer in feedlots. Item

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.